Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
131.73 | -10,39% | 2,75% | 333.646,57 | 2,39% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.72 | 18,28% | 40,89% | 188.694,61 | 2,01% | 15,98% |
|
SWX:NOVN
Novartis
|
93.30 | 8,23% | 21,62% | 190.369,92 | 3,53% | 4,67% |
|
SWX:ROG
Roche Holding
|
227.50 | 30,63% | 46,57% | 183.645,06 | 4,27% | 0,43% |
|
ENXTPA:SAN
Sanofi
|
90.56 | 17,5% | 36,18% | 113.210,59 | 4,1% | 8,19% |
|
LSE:GSK
GSK
|
18.13 | 5,18% | 20,68% | 73.914,43 | 3,2% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.55 | 59,85% | 70,07% | 90.307,31 | 5,37% | 13,54% |
|
ENXTPA:IPN
Ipsen
|
121.00 | -14,58% | -6,56% | 9.878,9 | 0,99% | 9,14% |
|
ENXTBR:SOLB
Solvay
|
34.10 | 17,96% | 41,12% | 3.611,22 | 7,04% | 9,75% |
|
NSEI:PFIZER
Pfizer
|
4314.15 | 14,48% | 21,43% | 194.757,24 | 0,81% | 10,3% |
|
HOSE:DHG
DHG Pharmaceutical Joint Stock
|
116400.00 | 24,25% | 39,02% | 14.918.126,7 | 3% | 0% |
|
ASX:MYX
Mayne Pharma Group
|
6.10 | -.102,84% | -.101,6% | 565,6 | 0% | 0% |
|
UNQ-VNM:PME
Pymepharco Joint Stock
|
80200.00 | -7,78% | 12,99% | 6.015.932,33 | 2,49% | -0,94% |
|
HOSE:IMP
Imexpharm
|
66300.00 | 15,58% | 0% | 4.557.302,65 | 1,45% | 0% |
|
HOSE:DBD
Binh Dinh Pharmaceutical and Medical
Equipment Joint Stock |
52300.00 | 31,14% | 0% | 3.974.188,47 | 3,8% | 21,39% |
|
HOSE:DCL
Cuu Long Pharmaceutical Joint Stock
|
30100.00 | 0% | 0% | 1.972.107,81 | 0% | 0% |
|
HOSE:DMC
Domesco Medical Import - Export
Joint-Stock |
56200.00 | 0% | 0% | 1.739.846 | 4,2% | 7,48% |
|
HOSE:OPC
OPC Pharmaceutical Joint Stock
|
23950.00 | 0% | 0% | 1.614.082,48 | 6,26% | 0% |
|
HNX:LDP
Lamdong Pharmaceutical Joint Stock
|
23000.00 | 0% | 0% | 284.550,22 | 0% | 0% |
|
HOSE:DBT
Ben Tre Pharmaceutical Joint Stock
|
12650.00 | 0% | 0% | 207.333,56 | 0% | 0% |
